448832004: Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Saxagliptin + Metformin\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing saxagliptin\Product containing metformin and saxagliptin (medicinal product)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing saxagliptin\Product containing metformin and saxagliptin (medicinal product)\Saxagliptin + Metformin\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing saxagliptin\Product containing saxagliptin in oral dose form (medicinal product form)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing saxagliptin\Product containing metformin and saxagliptin (medicinal product)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing saxagliptin\Product containing metformin and saxagliptin (medicinal product)\Saxagliptin + Metformin\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing saxagliptin\Product containing saxagliptin in oral dose form (medicinal product form)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Product containing metformin\Product containing metformin and saxagliptin (medicinal product)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Product containing metformin\Product containing metformin and saxagliptin (medicinal product)\Saxagliptin + Metformin\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing biguanide\Product containing metformin\Product containing metformin in oral dose form (medicinal product form)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing saxagliptin\Product containing metformin and saxagliptin (medicinal product)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing saxagliptin\Product containing metformin and saxagliptin (medicinal product)\Saxagliptin + Metformin\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing saxagliptin\Product containing saxagliptin in oral dose form (medicinal product form)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Product manufactured as oral dose form\Product containing saxagliptin in oral dose form (medicinal product form)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Product manufactured as oral dose form\Product containing metformin in oral dose form (medicinal product form)\Product containing metformin and saxagliptin in oral dose form (medicinal product form)\Product containing only metformin and saxagliptin in oral dose form (medicinal product form)\Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3761804014 Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

3761805010 Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	Metformin hydrochloride + saxagliptin	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	Combination oral hypoglycemic	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	Product manufactured as oral dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has active ingredient	Metformin hydrochloride	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has active ingredient	Saxagliptin	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	Extended-release tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	Product containing metformin in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	Prolonged-release oral tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance	Metformin hydrochloride	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance	Saxagliptin	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	500	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator value	5	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	Metformin hydrochloride	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	Saxagliptin hydrochloride	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	Product containing only metformin and saxagliptin in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3761804014	Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3761805010	Product containing precisely metformin hydrochloride 500 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each prolonged-release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module